Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zewei Wang

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Journal for Immunotherapy of Cancer|May 6, 2022
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerSen Yan, Han Zeng, Kaifeng Jin, et al.
Dalton Transactions (Cambridge, England : 2003)|November 17, 2021
Traditional Chinese medicine residue-derived micropore-rich porous carbon frameworks as efficient sulfur hosts for high-performance lithium-sulfur batteriesJunfei Liang, Yuqi Xu, Chao Li, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancerZhaopei Liu, Kaifeng Jin, Han Zeng, et al.
Angewandte Chemie (International Ed. in English)|March 24, 2017
Highly Branched Metal Alloy Networks with Superior Activities for the Methanol Oxidation ReactionXun Cui, Peng Xiao, Jing Wang, et al.
Oncoimmunology|November 18, 2017
High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patientsYu Zhu, Zheng Liu, Yiwei Wang, et al.
BMC Cancer|July 14, 2023
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerWandi Li, Zhaopei Liu, Kaifeng Jin, et al.
British Journal of Cancer|August 23, 2022
Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patientsChunnan Liu, Zhaopei Liu, Kaifeng Jin, et al.
Proceedings. IEEE International Conference on Healthcare Informatics|October 7, 2024
Analyzing Social Factors to Enhance Suicide Prevention Across Population GroupsRichard Li Xu, Song Wang, Zewei Wang, et al.
Biochemical and Biophysical Research Communications|August 23, 2020
Comparative analysis and functional identification of temperature-sensitive miRNA in Arabidopsis anthersYichun Lin, Luying Zhang, Yuanyuan Zhao, et al.
British Journal of Cancer|January 11, 2024
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancerXiaohe Su, Kaifeng Jin, Qiji Guo, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|May 6, 2022
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerSen Yan, Han Zeng, Kaifeng Jin, et al.
Dalton Transactions (Cambridge, England : 2003)|November 17, 2021
Traditional Chinese medicine residue-derived micropore-rich porous carbon frameworks as efficient sulfur hosts for high-performance lithium-sulfur batteriesJunfei Liang, Yuqi Xu, Chao Li, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancerZhaopei Liu, Kaifeng Jin, Han Zeng, et al.
Angewandte Chemie (International Ed. in English)|March 24, 2017
Highly Branched Metal Alloy Networks with Superior Activities for the Methanol Oxidation ReactionXun Cui, Peng Xiao, Jing Wang, et al.
Oncoimmunology|November 18, 2017
High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patientsYu Zhu, Zheng Liu, Yiwei Wang, et al.
BMC Cancer|July 14, 2023
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerWandi Li, Zhaopei Liu, Kaifeng Jin, et al.
British Journal of Cancer|August 23, 2022
Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patientsChunnan Liu, Zhaopei Liu, Kaifeng Jin, et al.
Proceedings. IEEE International Conference on Healthcare Informatics|October 7, 2024
Analyzing Social Factors to Enhance Suicide Prevention Across Population GroupsRichard Li Xu, Song Wang, Zewei Wang, et al.
Biochemical and Biophysical Research Communications|August 23, 2020
Comparative analysis and functional identification of temperature-sensitive miRNA in Arabidopsis anthersYichun Lin, Luying Zhang, Yuanyuan Zhao, et al.
British Journal of Cancer|January 11, 2024
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancerXiaohe Su, Kaifeng Jin, Qiji Guo, et al.
Pageof 16